Avalyn Pharma Inc. Insider Ownership Change Reported
Ticker: AVLN · Form: 4 · Filed: May 1, 2026 · CIK: 0001540171
| Field | Detail |
|---|---|
| Company | Avalyn Pharma Inc. (AVLN) |
| Form Type | 4 |
| Filed Date | May 1, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-transaction, ownership-change
TL;DR
Avalyn Pharma insider Turner changed ownership on 4/29/26. Details TBD.
AI Summary
On April 29, 2026, Heather D. Turner, a reporting person for Avalyn Pharma Inc., reported a change in beneficial ownership of securities. The filing details transactions related to Avalyn Pharma Inc. stock, but specific dollar amounts and the nature of the transactions are not provided in this excerpt.
Why It Matters
This filing indicates a change in insider holdings at Avalyn Pharma Inc., which can signal shifts in management's confidence or strategic direction.
Risk Assessment
Risk Level: medium — Form 4 filings can indicate insider trading activity, which may carry inherent risks depending on the nature of the transaction.
Key Players & Entities
- Heather D. Turner (person) — Reporting person for Avalyn Pharma Inc.
- Avalyn Pharma Inc. (company) — Issuer of securities
FAQ
What was the specific date of the reported ownership change?
The period of report was April 29, 2026.
Who is the reporting person associated with Avalyn Pharma Inc.?
Heather D. Turner is the reporting person.
What is the CIK for Avalyn Pharma Inc.?
The CIK for Avalyn Pharma Inc. is 0001540171.
What is the SIC code for Avalyn Pharma Inc.?
The SIC code for Avalyn Pharma Inc. is 2834, Pharmaceutical Preparations.
What is the filing date of this Form 4?
The filing date was May 1, 2026.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on May 1, 2026 by Heather D. Turner regarding Avalyn Pharma Inc. (AVLN). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.